Clinical trials query results
From Health Canada
- Medical condition:
- PLEURAL MESOTHELIOMA
- Study population:
- ADULT FEMALE,ADULT MALE
- Drug name:
- KEYTRUDA / ANETUMAB RAVTANSINE / GLUCOVISION
- Protocol title:
- PHASE 1 SAFETY RUN-IN AND PHASE 2 RANDOMIZED CLINICAL TRIAL OF ANETUMAB RAVTANSINE AND MK-3475 (PEMRBOLIZUMAB) COMPARED TO MK-3475 (PEMBROLIZUMAB) ALONE FOR MESOTHELIN-POSITIVE MALIGNANT PLEURAL MESOTHELIOMA
- Sponsor name:
- PRINCESS MARGARET PHASE I CONSORTIUM
- Date of no objection letter:
- 2018-11-20
- Control number:
- 221277
- Trial status:
- ONGOING
- Date study started:
- 2020-01-23